Glutathione

The Clearest Demonstration That Cysteine Is Limiting

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Paracetamol hepatotoxicity arises when a reactive metabolite depletes hepatic glutathione. The established antidote is N-acetylcysteine, which supplies cysteine for glutathione resynthesis rather than supplying glutathione itself — the practical demonstration, at scale, that cysteine is the limiting substrate.

Key facts

Reactive metabolite
NAPQI
Normally handled by
Conjugation with glutathione
Toxicity arises when
Glutathione is depleted
Antidote
N-acetylcysteine
What it supplies
Cysteine, not glutathione
Review
James 2003 (PMID 14625346)
Analogue work
Khayyat 2016 (PMID 26602168)

How the toxicity arises

Most paracetamol is cleared by conjugation to inactive products. A minor fraction is oxidised to a reactive metabolite, N-acetyl-p-benzoquinone imine, which is electrophilic and damaging. Under ordinary conditions glutathione conjugates it immediately and the amount formed is small enough that this is unproblematic.

What changes in overdose

The main conjugation routes saturate, so a larger proportion goes down the oxidative path and more reactive metabolite is produced. Glutathione is consumed conjugating it, and once the hepatic pool is substantially depleted the metabolite reaches cellular proteins instead. James reviewed this sequence in Drug Metabolism and Disposition in 2003.

Research material referenced

Glutathione 1500mg, third-party HPLC tested

Buy Glutathione · £38.99

Why glutathione depletion is the mechanism rather than a marker

The metabolite is not toxic because glutathione fell; it is toxic because nothing is left to conjugate it. Glutathione is the defence being exhausted, which makes this one of the clearest cases in pharmacology where a molecule's protective role is demonstrated by what happens in its absence.

Why the antidote supplies cysteine

N-acetylcysteine is a cysteine donor. It works by replenishing the substrate that limits glutathione synthesis, allowing the cell to rebuild its own pool. It does not supply glutathione. That choice is the practical demonstration of a point argued elsewhere on this site on theoretical grounds. Cysteine is the limiting substrate, so supplying cysteine addresses the actual constraint.

Why not simply give glutathione

Because the cell needs it inside, and glutathione is synthesised intracellularly through a regulated two-step pathway. Supplying the finished tripeptide externally faces the same difficulty described in this site's oral bioavailability article, while supplying cysteine feeds the existing route. The clinical world settled this question decades ago by choosing the precursor.

What is emphatically not being suggested

Paracetamol overdose is a medical emergency managed in hospital with monitoring and established protocols. Nothing here is guidance of any kind. N-acetylcysteine in that setting is a licensed medicine administered clinically, and nothing supplied on this site is a treatment for anything or has any role in any emergency.

Frequently asked questions

Why does paracetamol damage the liver in overdose?

The main clearance routes saturate, more reactive metabolite forms, and once glutathione is depleted there is nothing left to conjugate it.

Why is the antidote cysteine rather than glutathione?

Cysteine is the substrate limiting glutathione synthesis, so supplying it lets the cell rebuild its own pool through the regulated intracellular pathway.

What does this demonstrate?

That cysteine, not glutathione, is the limiting input. A point argued theoretically elsewhere and shown practically here.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Glutathione articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.